期刊
ANNALS OF ONCOLOGY
卷 21, 期 -, 页码 173-179出版社
ELSEVIER
DOI: 10.1093/annonc/mdq295
关键词
adverse effects; antineoplastic agents; arrhythmia; chemically induced heart diseases; heart failure; QTc prolongation
类别
Cancer treatment has improved extraordinarily in recent years. The development of targeted therapies has widened the cardiotoxic spectrum of antineoplastic drugs. Optimum management of cardiovascular disease before and during antineoplastic treatment is essential to reduce morbidity and mortality in cancer patients. This article reviews the incidence and characteristics of cardiotoxic effects of antineoplastic drugs with special focus on the pathophysiological mechanisms. It also emphasizes the importance of early detection and correction of cardiovascular risk factors and the relevance of close cardiac monitoring during antineoplastic treatment in order to reduce cardiotoxicity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据